G Nine Bioceuticals Private Limited

G Nine Bioceuticals Private Limited - pharma in Karnal, Haryana, India. FY 2026 financials & compliance.
CIN U74900HR2008PTC038275 Incorporated 19 August 2008 ROC Delhi HQ Karnal, Haryana, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹19.42 Cr
▲ 5% YoY
Net profit · FY 2025
₹57.29 Lakh
Net margin 3%
EBITDA · FY 2025
₹1.27 Cr
EBITDA margin 6.5%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹81.75 Lakh
Issued & subscribed
Open charges
₹3.9 Cr
Satisfied ₹6.88 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
5
Provident fund records

About G Nine Bioceuticals Private Limited

Data last updated:

G Nine Bioceuticals Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 August 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900HR2008PTC038275. Its GSTIN is 06AADCG2950K1ZL (Haryana).

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹81.75 Lakh. It is led by directors Robin and Narender Arora.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 208 – F Sector No.3 – A Hsidc Industrial Estate, Karnal, Haryana, India – 132001.

As per the financials filed for FY 2025, the company reported a revenue of ₹19.42 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹57.29 Lakh (net margin 3%) and EBITDA of ₹1.27 Cr (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 8% over five years.

The company has about 5 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: GNINE Bioceuticals. As per MCA filings, the company has open charges of ₹3.9 Cr and satisfied charges of ₹6.88 Cr on record. Court records list 3 cases involving the company, including 3 filed against it.

G Nine Bioceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0003245). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gninebio.in.

Company details

CIN U74900HR2008PTC038275
Registration Number 038275
Incorporation Date 19 August 2008
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-10-0003245
Key People
Robin Director Narender Arora Director

Recognitions & Rankings of G Nine Bioceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-HR-10-0003245

Contact details

G Nine Bioceuticals Private Limited's registered office is in Karnal, Haryana. Its website is gninebio.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    gninebio.in
  • Social Media
  • Registered Address
    208 – F Sector No.3 – A Hsidc Industrial Estate, Karnal, Haryana, India – 132001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of G Nine Bioceuticals Private Limited, buy the company report.

Comprehensive company report
G Nine Bioceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

G Nine Bioceuticals operates one associated brand: GNINE Bioceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
GNINE Bioceuticals
Manufacturing of pharmaceutical formulations and veterinary products in India.gninebio.com

Business activity

The main business activity of G Nine Bioceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of G Nine Bioceuticals Private Limited, buy the company report.

Financials of G Nine Bioceuticals Private Limited

FY 2025 filings available

G Nine Bioceuticals Private Limited reported revenue of ₹19.42 Cr (up 5% YoY) for FY 2025.

Revenue · FY 2025
₹19.42 Cr ▲ 5%
Net profit · FY 2025
₹57.29 Lakh margin 3%
EBITDA · FY 2025
₹1.27 Cr margin 6.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 3%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▼ 15%
3 years · compounded
▼ 16%
5 years · compounded
▲ 12%

Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 5% growth in the latest year. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.27 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹57.29 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6.5%
Net Profit Margin3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of G Nine Bioceuticals Private Limited, buy the company report.

Board of directors of G Nine Bioceuticals Private Limited

G Nine Bioceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
RobinDirector02 Jul 20206 Years 4 MonthsCurrent
Narender AroraDirector19 Aug 200818 Years 2 MonthsCurrent
View all directors

Peer comparison

G Nine Bioceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Aurz Pharmaceutical Private Limited₹19.44 Cr (FY 2025)10.0%Bangalore, Karnataka, India
Veco Labs Private Limited₹19.44 Cr (FY 2024)13.0%Hyderabad, Telangana, India
G Nine Bioceuticals Private Limitedthis company₹19.42 Cr (FY 2025)₹57.29 Lakh3%5.0%5Karnal, Haryana, India
Maneesh Chemicals Pvt Ltd₹19.4 Cr (FY 2024)18.0%Alwar, Rajasthan, India
Pass Microns Minerals Private Limited₹19.4 Cr (FY 2025)58.0%Delhi, India

To see the full peer comparison of G Nine Bioceuticals Private Limited, buy the company report.

Auditor

G Nine Bioceuticals Private Limited is audited by GROVER DINESH & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
GROVER DINESH & ASSOCIATESFY 2024012455N

Shareholding

The shareholding of G Nine Bioceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of G Nine Bioceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹3.9 Cr
Satisfied charges
₹6.88 Cr
Breakdown by lending institutions
Others₹3.90 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Dec 2024101044663Others₹2.5 CrOpen
21 Dec 2023100846983Others₹1.25 CrOpen
29 Jul 2021100465124Others₹15 LakhOpen
26 Mar 2021100448455Others₹24.95 LakhSatisfied
27 Feb 2017100097843Others₹2.99 CrSatisfied

To see the full charge records of G Nine Bioceuticals Private Limited, buy the company report.

Total charge records: 6 View all charges

MSME payment delays

G Nine Bioceuticals Private Limited has 13 MSME Form 1 returns on record between 2019 and 2024, listing 497 overdue payments to 30 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 30)

SupplierAmount dueDue sinceReported on
Ster Chem Gurgoan
an individual supplier
Del Trade International Private Limited
an individual supplier
Mediraw Pharma & Nutra Private Limited

To see the full MSME payment records of G Nine Bioceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

G Nine Bioceuticals Private Limited has a workforce of 5 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
5
Active EPFO establishments
1
Employee growth
-16.7%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-275
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of G Nine Bioceuticals Private Limited, buy the company report.

GST

G Nine Bioceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AADCG2950K1ZLHaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of G Nine Bioceuticals Private Limited, buy the company report.

Recent activity

G Nine Bioceuticals Private Limited has 6 board changes on record since 2008: 2 appointments and 4 cessations. The latest: Rajesh Kumar ceased to be Director on 03 Jul 2020.

AGM
G Nine Bioceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
G Nine Bioceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 2.50 Cr with Charge ID 101044663 was registered on 31 Dec 2024.
Charges
A charge with Others of Rs. 1.25 Cr registered on 21 Dec 2023 with Charge ID 100846983 was modified on 26 Jul 2024.
Charges
A charge registered on 26 Nov 2009 via Charge ID 10194849 with Punjab National Bank was fully satisfied on 22 Dec 2023.
Charges
A charge with Others amounted to Rs. 1.25 Cr with Charge ID 100846983 was registered on 21 Dec 2023.
Charges
A charge registered on 27 Feb 2017 via Charge ID 100097843 with Others was fully satisfied on 20 Dec 2023.
Charges
A charge registered on 26 Mar 2021 via Charge ID 100448455 with Others was fully satisfied on 13 Nov 2021.
Charges
A charge with Others amounted to Rs. 0.15 Cr with Charge ID 100465124 was registered on 29 Jul 2021.
Charges
A charge with Others amounted to Rs. 0.25 Cr with Charge ID 100448455 was registered on 26 Mar 2021.
Ceased
Rajesh Kumar ceased to be Director.
Ceased
Vridhi Arora ceased to be Director.

8 earlier events are in the company report.

Frequently asked questions

G Nine Bioceuticals is an active private limited company based in Karnal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 August 2008 (18+ years old) and is registered under CIN U74900HR2008PTC038275.

G Nine Bioceuticals has 2 current directors:

The latest financial statements of G Nine Bioceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of G Nine Bioceuticals is 06AADCG2950K1ZL, registered in Haryana.

The CIN (Corporate Identification Number) of G Nine Bioceuticals is U74900HR2008PTC038275. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

G Nine Bioceuticals has 3 court cases on record: 3 filed against it.

G Nine Bioceuticals was incorporated on 19 August 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of G Nine Bioceuticals by revenue are Aurz Pharmaceutical Private Limited, Veco Labs Private Limited, Maneesh Chemicals Pvt Ltd, Pass Microns Minerals Private Limited, all in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Rajesh Kumar ceased to be Director on 03 Jul 2020. Vridhi Arora ceased to be Director on 03 Jul 2020. Robin was appointed as Director on 02 Jul 2020. G Nine Bioceuticals has 6 board changes on record in total.

Yes, G Nine Bioceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-10-0003245).

G Nine Bioceuticals has 13 MSME Form 1 returns on record between 2019 and 2024, listing 497 overdue payments to 30 micro and small suppliers. The latest return was filed on 02 May 2024.

G Nine Bioceuticals can be reached through the website gninebio.in. Its registered office is in Karnal, Haryana, India.